Journal Article
. 2020 Oct; 12(10):.
doi: 10.3390/cancers12102838.

Blocking c-MET/ERBB1 Axis Prevents Brain Metastasis in ERBB2+ Breast Cancer

Shailendra K Gautam 1 Ranjana K Kanchan 1 Jawed A Siddiqui 1 Shailendra K Maurya 1 Sanchita Rauth 1 Naveenkumar Perumal 1 Pranita Atri 1 Ramakanth C Venkata 1 Kavita Mallya 1 Sameer Mirza 2 Moorthy P Ponnusamy 1 Vimla Band 1 Sidharth Mahapatra 1 Maneesh Jain 1 Surinder K Batra 1 Mohd Wasim Nasser 1 
Affiliations
  • PMID: 33019652
  •     79 References

Abstract

Brain metastasis (BrM) remains a significant cause of cancer-related mortality in epidermal growth factor receptor 2-positive (ERBB2+) breast cancer (BC) patients. We proposed here that a combination treatment of irreversible tyrosine kinase inhibitor neratinib (NER) and the c-MET inhibitor cabozantinib (CBZ) could prevent brain metastasis. To address this, we first tested the combination treatment of NER and CBZ in the brain-seeking ERBB2+ cell lines SKBrM3 and JIMT-1-BR3, and in ERBB2+ organoids that expressed the c-MET/ERBB1 axis. Next, we developed and characterized an orthotopic mouse model of spontaneous BrM and evaluated the therapeutic effect of CBZ and NER in vivo. The combination treatment of NER and CBZ significantly inhibited proliferation and migration in ERBB2+ cell lines and reduced the organoid growth in vitro. Mechanistically, the combination treatment of NER and CBZ substantially inhibited ERK activation downstream of the c-MET/ERBB1 axis. Orthotopically implanted SKBrM3+ cells formed primary tumor in the mammary fat pad and spontaneously metastasized to the brain and other distant organs. Combination treatment with NER and CBZ inhibited primary tumor growth and predominantly prevented BrM. In conclusion, the orthotopic model of spontaneous BrM is clinically relevant, and the combination therapy of NER and CBZ might be a useful approach to prevent BrM in BC.

Keywords: brain metastasis; breast cancer; c-MET/ERBB1 axis; cabozantinib; combination therapy; neratinib; organoids; orthotopic model; spontaneous metastasis; targeted therapy.

Epigenetic profiling for the molecular classification of metastatic brain tumors.
Javier I J Orozco, Theo A Knijnenburg, +16 authors, Diego M Marzese.
Nat Commun, 2018 Nov 08; 9(1). PMID: 30401823    Free PMC article.
Brain Complete Response to Cabozantinib prior to Radiation Therapy in Metastatic Renal Cell Carcinoma.
An Uche, Chad Sila, +5 authors, Jun Gong.
Case Rep Urol, 2019 Mar 25; 2019. PMID: 30906615    Free PMC article.
Extended Adjuvant Therapy with Neratinib Plus Fulvestrant Blocks ER/HER2 Crosstalk and Maintains Complete Responses of ER+/HER2+ Breast Cancers: Implications to the ExteNET Trial.
Dhivya R Sudhan, Luis J Schwarz, +12 authors, Carlos L Arteaga.
Clin Cancer Res, 2018 Oct 03; 25(2). PMID: 30274983    Free PMC article.
Safety and efficacy of neratinib in combination with weekly paclitaxel and trastuzumab in women with metastatic HER2‑positive breast cancer: an NSABP Foundation Research Program phase I study.
Rachel C Jankowitz, Jame Abraham, +6 authors, Samuel A Jacobs.
Cancer Chemother Pharmacol, 2013 Oct 01; 72(6). PMID: 24077916
EGFR and c-MET Cooperate to Enhance Resistance to PARP Inhibitors in Hepatocellular Carcinoma.
Qiongzhu Dong, Yi Du, +9 authors, Mien-Chie Hung.
Cancer Res, 2018 Dec 24; 79(4). PMID: 30573522    Free PMC article.
Organotropism: new insights into molecular mechanisms of breast cancer metastasis.
Wenjing Chen, Andrew D Hoffmann, Huiping Liu, Xia Liu.
NPJ Precis Oncol, 2018 Jun 07; 2(1). PMID: 29872722    Free PMC article.
Highly Cited. Review.
Function of the c-Met receptor tyrosine kinase in carcinogenesis and associated therapeutic opportunities.
Yazhuo Zhang, Mengfang Xia, +9 authors, Wei Xiong.
Mol Cancer, 2018 Feb 20; 17(1). PMID: 29455668    Free PMC article.
Highly Cited. Review.
Role of the Tumor Microenvironment in Breast Cancer.
Savas D Soysal, Alexandar Tzankov, Simone E Muenst.
Pathobiology, 2015 Sep 04; 82(3-4). PMID: 26330355
Review.
Safety and Efficacy of T-DM1 Plus Neratinib in Patients With Metastatic HER2-Positive Breast Cancer: NSABP Foundation Trial FB-10.
Jame Abraham, Albert J Montero, +15 authors, Samuel A Jacobs.
J Clin Oncol, 2019 Aug 24; 37(29). PMID: 31442103    Free PMC article.
Targeting MET and EGFR crosstalk signaling in triple-negative breast cancers.
Erik S Linklater, Elizabeth A Tovar, +10 authors, Carrie R Graveel.
Oncotarget, 2016 Sep 23; 7(43). PMID: 27655711    Free PMC article.
High expression of c-Met and EGFR is associated with poor survival of patients with glottic laryngeal squamous cell carcinoma.
Mei Jiang, Hui Zhang, +9 authors, Hualiang Xiao.
Oncol Lett, 2018 Feb 03; 15(1). PMID: 29391895    Free PMC article.
Subtype switching in breast cancer brain metastases: a multicenter analysis.
Alexander F C Hulsbergen, An Claes, +8 authors, Marike L D Broekman.
Neuro Oncol, 2020 Jan 24; 22(8). PMID: 31970416    Free PMC article.
Combination neratinib (HKI-272) and paclitaxel therapy in patients with HER2-positive metastatic breast cancer.
L W-C Chow, B Xu, +5 authors, I Bondarenko.
Br J Cancer, 2013 May 02; 108(10). PMID: 23632474    Free PMC article.
Genes that mediate breast cancer metastasis to lung.
Andy J Minn, Gaorav P Gupta, +7 authors, Joan Massagué.
Nature, 2005 Jul 29; 436(7050). PMID: 16049480    Free PMC article.
Highly Cited.
Central Nervous System Metastasis in Patients with HER2-Positive Metastatic Breast Cancer: Patient Characteristics, Treatment, and Survival from SystHERs.
Sara A Hurvitz, Joyce O'Shaughnessy, +11 authors, Melody Cobleigh.
Clin Cancer Res, 2018 Dec 30; 25(8). PMID: 30593513
A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivity.
P R Twentyman, M Luscombe.
Br J Cancer, 1987 Sep 01; 56(3). PMID: 3663476    Free PMC article.
Highly Cited.
Synergism of EGFR and c-Met pathways, cross-talk and inhibition, in non-small cell lung cancer.
Neelu Puri, Ravi Salgia.
J Carcinog, 2009 Feb 26; 7. PMID: 19240370    Free PMC article.
Characterization of a novel cell line established from a patient with Herceptin-resistant breast cancer.
Minna Tanner, Anita I Kapanen, +5 authors, Jorma Isola.
Mol Cancer Ther, 2005 Jan 07; 3(12). PMID: 15634652
Combination therapies for the treatment of HER2-positive breast cancer: current and future prospects.
Mariana Brandão, Noam F Pondé, +4 authors, Evandro de Azambuja.
Expert Rev Anticancer Ther, 2018 May 22; 18(7). PMID: 29781317
Review.
Mucins and associated O-glycans based immunoprofile for stratification of colorectal polyps: clinical implication for improved colon surveillance.
Shiv Ram Krishn, Sukhwinder Kaur, +9 authors, Surinder K Batra.
Oncotarget, 2016 Oct 06; 8(4). PMID: 27705923    Free PMC article.
Activation of the c-Met Pathway Mobilizes an Inflammatory Network in the Brain Microenvironment to Promote Brain Metastasis of Breast Cancer.
Fei Xing, Yin Liu, +9 authors, Kounosuke Watabe.
Cancer Res, 2016 Jul 02; 76(17). PMID: 27364556    Free PMC article.
Development and characterization of carboxy-terminus specific monoclonal antibodies for understanding MUC16 cleavage in human ovarian cancer.
Abhijit Aithal, Wade M Junker, +10 authors, Maneesh Jain.
PLoS One, 2018 May 01; 13(4). PMID: 29708979    Free PMC article.
Metastatic colonization by circulating tumour cells.
Joan Massagué, Anna C Obenauf.
Nature, 2016 Jan 23; 529(7586). PMID: 26791720    Free PMC article.
Highly Cited. Review.
RNA Polymerase II-Associated Factor 1 Regulates Stem Cell Features of Pancreatic Cancer Cells, Independently of the PAF1 Complex, via Interactions With PHF5A and DDX3.
Saswati Karmakar, Sanchita Rauth, +10 authors, Surinder K Batra.
Gastroenterology, 2020 Aug 12; 159(5). PMID: 32781084    Free PMC article.
HER2-targeted therapies - a role beyond breast cancer.
Do-Youn Oh, Yung-Jue Bang.
Nat Rev Clin Oncol, 2019 Sep 25; 17(1). PMID: 31548601
Review.
Western blotting.
Biji T Kurien, R Hal Scofield.
Methods, 2006 Feb 18; 38(4). PMID: 16483794
Cancer statistics, 2020.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal.
CA Cancer J Clin, 2020 Jan 09; 70(1). PMID: 31912902
Highly Cited.
Loss of XIST in Breast Cancer Activates MSN-c-Met and Reprograms Microglia via Exosomal miRNA to Promote Brain Metastasis.
Fei Xing, Yin Liu, +17 authors, Kounosuke Watabe.
Cancer Res, 2018 Jul 22; 78(15). PMID: 30026327    Free PMC article.
Highly Cited.
Targeting MET as a strategy to overcome crosstalk-related resistance to EGFR inhibitors.
Michalis V Karamouzis, Panagiotis A Konstantinopoulos, Athanasios G Papavassiliou.
Lancet Oncol, 2009 Jul 04; 10(7). PMID: 19573800
Review.
Cell migration and invasion assays as tools for drug discovery.
Keren I Hulkower, Renee L Herber.
Pharmaceutics, 2011 Jan 01; 3(1). PMID: 24310428    Free PMC article.
Highly Cited.
MUC16 Regulates TSPYL5 for Lung Cancer Cell Growth and Chemoresistance by Suppressing p53.
Imayavaramban Lakshmanan, Shereen Salfity, +10 authors, Apar Kishor Ganti.
Clin Cancer Res, 2017 Feb 16; 23(14). PMID: 28196872    Free PMC article.
microRNAs Orchestrate Pathophysiology of Breast Cancer Brain Metastasis: Advances in Therapy.
Ranjana K Kanchan, Jawed A Siddiqui, +2 authors, Mohd W Nasser.
Mol Cancer, 2020 Feb 16; 19(1). PMID: 32059676    Free PMC article.
Review.
Heterogeneity and vascular permeability of breast cancer brain metastases.
Maria V Babak, Michael R Zalutsky, Irina V Balyasnikova.
Cancer Lett, 2020 Jun 21; 489. PMID: 32561415    Free PMC article.
Trastuzumab Emtansine With or Without Pertuzumab Versus Trastuzumab Plus Taxane for Human Epidermal Growth Factor Receptor 2-Positive, Advanced Breast Cancer: Primary Results From the Phase III MARIANNE Study.
Edith A Perez, Carlos Barrios, +12 authors, Paul Ellis.
J Clin Oncol, 2017 Jan 06; 35(2). PMID: 28056202    Free PMC article.
Highly Cited.
Tumor Organoids as a Pre-clinical Cancer Model for Drug Discovery.
Fleur Weeber, Salo N Ooft, Krijn K Dijkstra, Emile E Voest.
Cell Chem Biol, 2017 Aug 02; 24(9). PMID: 28757181
Highly Cited. Review.
Cancer statistics, 2019.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal.
CA Cancer J Clin, 2019 Jan 09; 69(1). PMID: 30620402
Highly Cited.
Therapy Landscape in Patients with Metastatic HER2-Positive Breast Cancer: Data from the PRAEGNANT Real-World Breast Cancer Registry.
Michael P Lux, Naiba Nabieva, +28 authors, Sara Y Brucker.
Cancers (Basel), 2018 Dec 24; 11(1). PMID: 30577662    Free PMC article.
Mouse models for breast cancer metastasis.
Ik Soo Kim, Sung Hee Baek.
Biochem Biophys Res Commun, 2010 Mar 17; 394(3). PMID: 20230796
Review.
The Association between EGFR and cMET Expression and Phosphorylation and Its Prognostic Implication in Patients with Breast Cancer.
Young Kwang Chae, Debora de Melo Gagliato, +10 authors, Ana Maria Gonzalez-Angulo.
PLoS One, 2016 Apr 08; 11(4). PMID: 27055285    Free PMC article.
Cucurbitacin E inhibits breast tumor metastasis by suppressing cell migration and invasion.
Tao Zhang, Jingjie Li, +7 authors, Zhengfang Yi.
Breast Cancer Res Treat, 2012 Jul 31; 135(2). PMID: 22842972
From breast to the brain: unraveling the puzzle of metastasis organotropism.
Guohong Hu, Yibin Kang, Xiao-Fan Wang.
J Mol Cell Biol, 2009 Jul 28; 1(1). PMID: 19633017
Neratinib Efficacy and Circulating Tumor DNA Detection of HER2 Mutations in HER2 Nonamplified Metastatic Breast Cancer.
Cynthia X Ma, Ron Bose, +27 authors, Matthew J C Ellis.
Clin Cancer Res, 2017 Jul 07; 23(19). PMID: 28679771    Free PMC article.
Highly Cited.
Changing molecular profile of brain metastases compared with matched breast primary cancers and impact on clinical outcomes.
A H Thomson, J McGrane, +4 authors, R Jenkins.
Br J Cancer, 2016 Feb 26; 114(7). PMID: 26908328    Free PMC article.
An Orthotopic Mouse Model of Spontaneous Breast Cancer Metastasis.
Amy V Paschall, Kebin Liu.
J Vis Exp, 2016 Sep 02; (114). PMID: 27584043    Free PMC article.
TBCRC 022: A Phase II Trial of Neratinib and Capecitabine for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases.
Rachel A Freedman, Rebecca S Gelman, +28 authors, Translational Breast Cancer Research Consortium.
J Clin Oncol, 2019 Mar 13; 37(13). PMID: 30860945    Free PMC article.
Highly Cited.
Breast cancers with EGFR and HER2 co-amplification favor distant metastasis and poor clinical outcome.
Peng Guo, Tianjie Pu, +6 authors, Feng Ye.
Oncol Lett, 2017 Nov 29; 14(6). PMID: 29181099    Free PMC article.
Dual inhibition of EGFR and c-Met kinase activation by MJ-56 reduces metastasis of HT29 human colorectal cancer cells.
Hui-Jye Chen, Yi-Lin Jiang, +5 authors, Jai-Sing Yang.
Int J Oncol, 2013 May 17; 43(1). PMID: 23677180
Comparison of breast cancer metastasis models reveals a possible mechanism of tumor aggressiveness.
Nir Pillar, Avital Luba Polsky, Daphna Weissglas-Volkov, Noam Shomron.
Cell Death Dis, 2018 Oct 12; 9(10). PMID: 30305609    Free PMC article.
Ca2+ and CACNA1H mediate targeted suppression of breast cancer brain metastasis by AM RF EMF.
Sambad Sharma, Shih-Ying Wu, +19 authors, Kounosuke Watabe.
EBioMedicine, 2019 May 28; 44. PMID: 31129098    Free PMC article.
Brain tumor vessels-a barrier for drug delivery.
Casper Hempel, Kasper B Johnsen, +2 authors, Thomas L Andresen.
Cancer Metastasis Rev, 2020 Jun 04; 39(3). PMID: 32488404
Review.
A new mouse model for the study of human breast cancer metastasis.
Elizabeth Iorns, Katherine Drews-Elger, +5 authors, Marc Lippman.
PLoS One, 2012 Nov 03; 7(10). PMID: 23118918    Free PMC article.
Therapy of breast cancer brain metastases: challenges, emerging treatments and perspectives.
Nuria Kotecki, Florence Lefranc, Daniel Devriendt, Ahmad Awada.
Ther Adv Med Oncol, 2018 Jul 07; 10. PMID: 29977353    Free PMC article.
Review.
Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer.
Hervé Tiriac, Pascal Belleau, +67 authors, David A Tuveson.
Cancer Discov, 2018 Jun 02; 8(9). PMID: 29853643    Free PMC article.
Highly Cited.
Metastasis: from dissemination to organ-specific colonization.
Don X Nguyen, Paula D Bos, Joan Massagué.
Nat Rev Cancer, 2009 Mar 25; 9(4). PMID: 19308067
Highly Cited. Review.
Efficacy and safety of trastuzumab emtansine (T-DM1) in the treatment of HER2-positive metastatic breast cancer (MBC): a meta-analysis of randomized controlled trial.
Hongjing Yan, Kewei Yu, +2 authors, Yue Li.
Oncotarget, 2017 Dec 20; 8(60). PMID: 29254261    Free PMC article.
CXCL1 derived from tumor-associated macrophages promotes breast cancer metastasis via activating NF-κB/SOX4 signaling.
Neng Wang, Weiping Liu, +8 authors, Zhiyu Wang.
Cell Death Dis, 2018 Aug 31; 9(9). PMID: 30158589    Free PMC article.
Fibroblast-derived CXCL12 promotes breast cancer metastasis by facilitating tumor cell intravasation.
Dinesh K Ahirwar, Mohd W Nasser, +11 authors, Ramesh K Ganju.
Oncogene, 2018 May 04; 37(32). PMID: 29720724    Free PMC article.
A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity.
Norman Sachs, Joep de Ligt, +28 authors, Hans Clevers.
Cell, 2017 Dec 12; 172(1-2). PMID: 29224780
Highly Cited.
Cabozantinib for metastatic breast carcinoma: results of a phase II placebo-controlled randomized discontinuation study.
Sara M Tolaney, Hovav Nechushtan, +7 authors, Eric P Winer.
Breast Cancer Res Treat, 2016 Oct 08; 160(2). PMID: 27714541    Free PMC article.
Understanding patterns of brain metastasis in breast cancer and designing rational therapeutic strategies.
Evelyn M Brosnan, Carey K Anders.
Ann Transl Med, 2018 Jun 19; 6(9). PMID: 29911111    Free PMC article.
Review.
Challenges in the Treatment of Triple Negative and HER2-Overexpressing Breast Cancer.
L Alexis Hoeferlin, Charles E Chalfant, Margaret A Park.
J Surg Sci, 2014 May 13; 1(1). PMID: 24818173    Free PMC article.
Cabozantinib suppresses tumor growth and metastasis in hepatocellular carcinoma by a dual blockade of VEGFR2 and MET.
Qingfeng Xiang, Weiqiang Chen, +6 authors, Yajin Chen.
Clin Cancer Res, 2014 Apr 05; 20(11). PMID: 24700742
Neoadjuvant neratinib promotes ferroptosis and inhibits brain metastasis in a novel syngeneic model of spontaneous HER2+ve breast cancer metastasis.
Aadya Nagpal, Richard P Redvers, +12 authors, Normand Pouliot.
Breast Cancer Res, 2019 Aug 15; 21(1). PMID: 31409375    Free PMC article.
In vivo bioluminescence imaging of tumor hypoxia dynamics of breast cancer brain metastasis in a mouse model.
Debabrata Saha, Henry Dunn, +4 authors, Dawen Zhao.
J Vis Exp, 2011 Oct 13; (56). PMID: 21989061    Free PMC article.
Molecular characterization of breast cancer CTCs associated with brain metastasis.
Debasish Boral, Monika Vishnoi, +8 authors, Dario Marchetti.
Nat Commun, 2017 Aug 05; 8(1). PMID: 28775303    Free PMC article.
Highly Cited.
Actein Inhibits Tumor Growth and Metastasis in HER2-Positive Breast Tumor Bearing Mice via Suppressing AKT/mTOR and Ras/Raf/MAPK Signaling Pathways.
Xiao-Xiao Wu, Grace Gar-Lee Yue, +4 authors, Clara Bik-San Lau.
Front Oncol, 2020 Jun 18; 10. PMID: 32547952    Free PMC article.
Quantification of metastatic load in a syngeneic murine model of metastasis.
Luke J Taus, Roberto E Flores, Thomas N Seyfried.
Cancer Lett, 2017 Jul 22; 405. PMID: 28729049
Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors.
Andy J Minn, Yibin Kang, +7 authors, Joan Massagué.
J Clin Invest, 2005 Jan 05; 115(1). PMID: 15630443    Free PMC article.
Highly Cited.
Time trends of overall survival among metastatic breast cancer patients in the real-life ESME cohort.
Elisa Gobbini, Monia Ezzalfani, +25 authors, Suzette Delaloge.
Eur J Cancer, 2018 Apr 17; 96. PMID: 29660596
Highly Cited.
Safety and efficacy of neratinib in combination with capecitabine in patients with metastatic human epidermal growth factor receptor 2-positive breast cancer.
Cristina Saura, Jose A Garcia-Saenz, +10 authors, Sung-Bae Kim.
J Clin Oncol, 2014 Oct 08; 32(32). PMID: 25287822
Patient-derived lung cancer organoids as in vitro cancer models for therapeutic screening.
Minsuh Kim, Hyemin Mun, +13 authors, Se Jin Jang.
Nat Commun, 2019 Sep 07; 10(1). PMID: 31488816    Free PMC article.
Highly Cited.
Cigarette Smoke Induces Stem Cell Features of Pancreatic Cancer Cells via PAF1.
Rama Krishna Nimmakayala, Parthasarathy Seshacharyulu, +14 authors, Moorthy P Ponnusamy.
Gastroenterology, 2018 Jun 05; 155(3). PMID: 29864419    Free PMC article.
Impact of molecular subtypes on metastatic breast cancer patients: a SEER population-based study.
Yue Gong, Yi-Rong Liu, +2 authors, Zhi-Ming Shao.
Sci Rep, 2017 Mar 28; 7. PMID: 28345619    Free PMC article.
Strikingly different angiogenic properties of endothelial progenitor cell subpopulations: insights from a novel human angiogenesis assay.
Daniel P Sieveking, Andrew Buckle, David S Celermajer, Martin K C Ng.
J Am Coll Cardiol, 2008 Feb 12; 51(6). PMID: 18261686
Highly Cited.
EGFR Gene Amplification and Protein Expression in Invasive Ductal Carcinoma of the Breast.
Won Hwangbo, Jeong Hyeon Lee, +4 authors, Insun Kim.
Korean J Pathol, 2013 May 15; 47(2). PMID: 23667369    Free PMC article.
Individualized Prediction of Survival Benefit From Locoregional Surgical Treatment for Patients With Metastatic Breast Cancer.
Yajuan Zheng, Guansheng Zhong, +2 authors, Qiong Yang.
Front Oncol, 2020 Mar 07; 10. PMID: 32133290    Free PMC article.
A phase II study of cabozantinib alone or in combination with trastuzumab in breast cancer patients with brain metastases.
José Pablo Leone, Dan G Duda, +9 authors, Sara M Tolaney.
Breast Cancer Res Treat, 2019 Sep 22; 179(1). PMID: 31541381
Tumor-associated stromal cells as key contributors to the tumor microenvironment.
Karen M Bussard, Lysette Mutkus, +2 authors, Frank C Marini.
Breast Cancer Res, 2016 Aug 16; 18(1). PMID: 27515302    Free PMC article.
Highly Cited. Review.
Identification of brain metastasis genes and therapeutic evaluation of histone deacetylase inhibitors in a clinically relevant model of breast cancer brain metastasis.
Soo-Hyun Kim, Richard P Redvers, +8 authors, Normand Pouliot.
Dis Model Mech, 2018 May 23; 11(7). PMID: 29784888    Free PMC article.